Back
Galera Therapeutics Vs. Novabay Pharmaceuticals Industry Stock Comparison
Sell
15
GRTX
Galera Therapeutics
Last Price:
$0.02
Seasonality Move:
-29.3%
Sell
24
NBY
Novabay Pharmaceuticals
Last Price:
$0.62
Seasonality Move:
-16.45%
Sell
15
Galera Therapeutics (GRTX)
is a Sell
Is Galera Therapeutics a Buy, Sell or Hold?
-
The current Galera Therapeutics [GRTX] share price is $0.02. The Score for GRTX is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
GRTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
24
Novabay Pharmaceuticals (NBY)
is a Sell
Is Novabay Pharmaceuticals a Buy, Sell or Hold?
-
The current Novabay Pharmaceuticals [NBY] share price is $0.62. The Score for NBY is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GRTX Stock Price Chart
What is Galera Therapeutics's stock price today?
-
The Galera Therapeutics share price today is $0.02Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GRTX is experiencing slight buying pressure.
NBY Stock Price Chart
What is Novabay Pharmaceuticals's stock price today?
-
The Novabay Pharmaceuticals share price today is $0.62Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
GRTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 42.32 | Sell |
Chaikin Money Flow: | 7670 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.02 - 0.02) | Buy |
Bollinger Bands (100): | (0.03 - 0.03) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 51.1 | Buy |
Chaikin Money Flow: | 199888 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.6 - 0.66) | Sell |
Bollinger Bands (100): | (0.55 - 0.63) | Buy |
GRTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.02 | Sell |
20-day SMA: | 0.02 | Sell |
50-day SMA: | 0.03 | Sell |
200-day SMA: | 0.03 | Sell |
8-day EMA: | 0.02 | Sell |
20-day EMA: | 0.02 | Buy |
50-day EMA: | 0.02 | Buy |
200-day EMA: | 0.01 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.6 | Buy |
20-day SMA: | 0.62 | Buy |
50-day SMA: | 0.62 | Sell |
200-day SMA: | 0.62 | Sell |
8-day EMA: | 0.58 | Buy |
20-day EMA: | 0.45 | Buy |
50-day EMA: | 0.26 | Buy |
200-day EMA: | 0.08 | Buy |
Galera Therapeutics Earnings Growth & GRTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novabay Pharmaceuticals Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.57 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
Galera Therapeutics Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novabay Pharmaceuticals Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |